Bloomberg Sanofi agreed to buy Belgium’s Ablynx NV for $4.8 billion, outbidding rival Novo Nordisk A/S to gain a potential blockbuster for a rare blood clotting disease. Paris-based Sanofi will pay 45 euros a share in cash for all outstanding shares of Ablynx, it said. The price is 48 percent above Novo’s unsolicited offer of as much as 30.50 euros ...

Bloomberg The euro area is set to start the new year the way it ended the old: the economy is strong but inflation is weak. The region’s fastest growth in a decade will be confirmed this week in a burst of data that should also show economic confidence at the highest since the currency bloc’s early days, unemployment at a ...

Bloomberg There’s nothing like $1.5 trillion in tax cuts to help make friends at a gathering of conservative political donors. Donald Trump is gaining ground with members to the Koch political network, after the president’s name was hardly mentioned when the deep-pocketed individuals last assembled seven months ago. At that time, the group was skeptical of the former New York ...